Literature DB >> 20230819

PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.

Zahra Faghiri1, Nicolas G Bazan.   

Abstract

The initiation and progression of several forms of retinal degenerations involve excessive, repetitive, and/or sustained oxidative stress that, in turn, mediate photoreceptor cell damage and death. Since phosphatidylinositol 3-kinase (PI3K)/Akt and mTOR/p70S6-kinase pathways are part of survival signaling in cells confronted with oxidative stress, we asked whether or not docosahexaenoic acid-derived neuroprotectin D1 (NPD1) mediates survival upon single-dose and/or repetitive oxidative stress through this pathway. For this purpose, we used human retinal pigment epithelial (ARPE-19) cells challenged by exposure to hydrogen peroxide (H(2)O(2)) plus tumor necrosis factor alpha (TNF-alpha). We found that in single-dose oxidative stress-induced apoptosis, phosphorylation of Akt, mTOR, and p70S6K was both time- and dose- dependent. Inhibition of PI3K or mTOR/p70S6K by wortmannin and rapamycin, respectively, increased apoptosis and inhibited phosphorylation of Akt and p70S6K induced by single-dose oxidative stress. While two exposures of a low dose, non-damaging oxidation induced apoptosis and upregulation of Akt, mTOR, and p70S6K, longer treatment of the cells with three exposures of low dose to low-dose stress showed no changes in the levels of Akt, mTOR, or p70S6K, and resulted in enhanced apoptosis compared to higher doses. Removing the oxidative stress-inducing agents following the single-dose or short term repetitive oxidative stress at the peak of Akt, mTOR, and p70S6K phosphorylation (i.e., 30 min after induction) led to recovery, with no apoptosis after 16 h of incubation. Cells that were induced with three low doses of stress did not show recovery when oxidative stress was removed 30 min after the last exposure. NPD1 protected the RPE cells against both single-dose and repetitive oxidative stress-induced apoptosis and promoted higher levels of phosphorylated Akt, mTOR, and p70S6K. Together, our results show that a) repetitive oxidative stress is dose dependent and may not be recovered by removing the oxidative stress-inducing agents, b) PI3K/Akt and mTOR/p70S6K pathways play a major role in the protection against oxidative stress-induced apoptosis in ARPE-19 cells, and c) NPD1 exerts protection under these conditions by inducing PI3K/Akt and mTOR/p70S6K pathways. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230819      PMCID: PMC2873108          DOI: 10.1016/j.exer.2010.03.002

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  24 in total

Review 1.  The phosphoinositide 3-kinase pathway.

Authors:  Lewis C Cantley
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

2.  ABCR, the ATP-binding cassette transporter responsible for Stargardt macular dystrophy, is an efficient target of all-trans-retinal-mediated photooxidative damage in vitro. Implications for retinal disease.

Authors:  H Sun; J Nathans
Journal:  J Biol Chem       Date:  2001-01-23       Impact factor: 5.157

Review 3.  Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration.

Authors:  Fong-Qi Liang; Bernard F Godley
Journal:  Exp Eye Res       Date:  2003-04       Impact factor: 3.467

Review 4.  Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.

Authors:  Nicolas G Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

5.  Oxidative damage in age-related macular degeneration.

Authors:  J K Shen; A Dong; S F Hackett; W R Bell; W R Green; P A Campochiaro
Journal:  Histol Histopathol       Date:  2007-12       Impact factor: 2.303

6.  The use of hyperoxia to induce chronic mild oxidative stress in RPE cells in vitro.

Authors:  S Honda; L M Hjelmeland; J T Handa
Journal:  Mol Vis       Date:  2001-03-14       Impact factor: 2.367

Review 7.  Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review.

Authors:  R Witkamp; M Monshouwer
Journal:  Vet Q       Date:  2000-01       Impact factor: 3.320

8.  Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes.

Authors:  Heidi Glosli; Karl Johan Tronstad; Hege Wergedal; Fredrik Müller; Asbjørn Svardal; Pål Aukrust; Rolf Kristian Berge; Hans Prydz
Journal:  FASEB J       Date:  2002-07-18       Impact factor: 5.191

9.  Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils.

Authors:  Victor L Marcheselli; Pranab K Mukherjee; Makoto Arita; Song Hong; Rajee Antony; Kristopher Sheets; Jeremy W Winkler; Nicos A Petasis; Charles N Serhan; Nicolas G Bazan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-01       Impact factor: 4.006

10.  Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway.

Authors:  Xiaolin Wan; Lee J Helman
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

View more
  46 in total

1.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

Review 2.  The role of pro-resolving lipid mediators in ocular diseases.

Authors:  Jessica Wei; Karsten Gronert
Journal:  Mol Aspects Med       Date:  2017-04-06

3.  Essential Role of mTOR Signaling in Human Retinal Pigment Epithelial Cell Regeneration After Laser Photocoagulation.

Authors:  Sanjar Batirovich Madrakhimov; Jin Young Yang; Ha Yan Park; Tae Kwann Park
Journal:  Lasers Med Sci       Date:  2018-11-29       Impact factor: 3.161

4.  Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.

Authors:  Yao-Wu Liu; Liang Zhang; Yu Li; Ya-Qin Cheng; Xia Zhu; Fan Zhang; Xiao-Xing Yin
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

5.  Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.

Authors:  Kun-Che Chang; Jessica Ponder; Daniel V Labarbera; J Mark Petrash
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

6.  Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes.

Authors:  Song Hong; Haibin Tian; Yan Lu; James Monroe Laborde; Filipe A Muhale; Quansheng Wang; Bhagwat V Alapure; Charles N Serhan; Nicolas G Bazan
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-01       Impact factor: 4.249

Review 7.  Cutting through the complexities of mTOR for the treatment of stroke.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014-05       Impact factor: 1.990

8.  NPD1 induction of retinal pigment epithelial cell survival involves PI3K/Akt phosphorylation signaling.

Authors:  Natalie A Halapin; Nicolas G Bazan
Journal:  Neurochem Res       Date:  2010-12-07       Impact factor: 3.996

Review 9.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

10.  Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes.

Authors:  Ly Q Hong-Brown; C Randell Brown; Maithili Navaratnarajah; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2013-07-29       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.